These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31005061)

  • 1. Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia.
    Hui M; Sheppard JI; Li N; Warkentin TE
    Thromb Haemost; 2019 Jun; 119(6):941-951. PubMed ID: 31005061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood.
    Khairy M; Lasne D; Amelot A; Crespin M; Rendu F; Aiach M; Bachelot-Loza C
    Thromb Haemost; 2004 Dec; 92(6):1411-9. PubMed ID: 15583751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Soini B; Ramon R; Scandellari R; Randi ML; Girolami A
    J Intern Med; 2002 Aug; 252(2):149-54. PubMed ID: 12190890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases.
    Refaai MA; Van Cott EM; Laposata M
    Am J Clin Pathol; 2003 Apr; 119(4):497-504. PubMed ID: 12710122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
    Castelli R; Cassinerio E; Cappellini MD; Porro F; Graziadei G; Fabris F
    Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):153-62. PubMed ID: 17896955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy].
    Folwaczny EK; Stürmer KM
    Chirurg; 2002 Dec; 73(12):1197-203. PubMed ID: 12491049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Autoimmun Rev; 2002 May; 1(3):125-32. PubMed ID: 12849005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients.
    Greinacher A; Farner B; Kroll H; Kohlmann T; Warkentin TE; Eichler P
    Thromb Haemost; 2005 Jul; 94(1):132-5. PubMed ID: 16113796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
    Warkentin TE; Roberts RS; Hirsh J; Kelton JG
    Arch Intern Med; 2003 Nov; 163(20):2518-24. PubMed ID: 14609790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
    Greinacher A; Warkentin TE
    Expert Rev Hematol; 2008 Oct; 1(1):75-85. PubMed ID: 21083008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
    Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
    Rollin J; Pouplard C; Gruel Y
    Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of heparin-induced thrombocytopenia].
    Wang JH; Wang CY; Xie R; Che DH; Jia RC; Ju W; Miao MJ; Wang H; Jiang Y; Tong DX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):115-7. PubMed ID: 21429379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of current strategies in the prevention of thrombosis in patients with heparin-induced thrombocytopenia: a clinician's perspective.
    Wallis DE; Lewis BE; Walenga JM
    Semin Thromb Hemost; 1999; 25 Suppl 1():3-7. PubMed ID: 10357145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allergic thrombocytopenia to heparin].
    Letawe-Gilis L; David JL
    Rev Med Liege; 2001 Jul; 56(7):489-92. PubMed ID: 11523299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.